Dermata Therapeutics Correlations

DRMA Stock

USD 2.18 0.08 3.54%

The current 90-days correlation between Dermata Therapeutics and GT Biopharma is -0.25 (i.e., Very good diversification). The correlation of Dermata Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Dermata Therapeutics Correlation With Market

Significant diversification

The correlation between Dermata Therapeutics and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Dermata Stock

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dermata Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For information on how to trade Dermata Stock refer to our How to Trade Dermata Stock guide.

Moving together with Dermata Stock

0.9	LIPO	Lipella Pharmaceuticals	Pair Corr
0.81	HPQ	HP Inc	Pair Corr
0.85	HD	Home Depot	Pair Corr

Moving against Dermata Stock

0.89	DD	Dupont De Nemours	Pair Corr
0.88	ATI	Allegheny Technologies	Pair Corr
0.82	CSCO	Cisco Systems	Pair Corr
0.81	BAC	Bank of America Earnings Call This Week	Pair Corr
0.79	AXP	American Express	Pair Corr
0.78	AMGN	Amgen Inc	Pair Corr
0.78	XOM	Exxon Mobil Corp	Pair Corr
0.77	BOF	BranchOut Food Common	Pair Corr
0.77	JNJ	Johnson Johnson	Pair Corr
0.75	F	Ford Motor Aggressive Push	Pair Corr
0.74	WSFS	WSFS Financial	Pair Corr
0.72	TRV	The Travelers Companies	Pair Corr
0.64	ACN	Accenture plc	Pair Corr
0.64	JPM	JPMorgan Chase Earnings Call This Week	Pair Corr
0.63	GILD	Gilead Sciences	Pair Corr
0.58	KO	Coca Cola	Pair Corr
0.5	IBM	International Business	Pair Corr
0.42	MMM	3M Company	Pair Corr
0.38	PFE	Pfizer Inc	Pair Corr
0.37	ASXSF	Elysee Development Corp	Pair Corr
0.33	ACR-PC	ACRES Commercial Realty	Pair Corr

Related Correlations Analysis

	ATXI	WINT	CARM	PBM	LIPO	VRAX	ELAB	GTBP	REVB	ARTL
ATXI		0.2	-0.01	0.36	0.42	0.25	0.52	-0.13	0.09	0.14	ATXI
WINT	0.2		0.28	0.87	0.83	0.8	0.8	-0.25	0.84	0.87	WINT
CARM	-0.01	0.28		0.44	0.44	0.44	0.19	0.22	0.57	0.59	CARM
PBM	0.36	0.87	0.44		0.95	0.84	0.86	-0.19	0.84	0.87	PBM
LIPO	0.42	0.83	0.44	0.95		0.77	0.87	-0.14	0.76	0.83	LIPO
VRAX	0.25	0.8	0.44	0.84	0.77		0.76	-0.29	0.86	0.84	VRAX
ELAB	0.52	0.8	0.19	0.86	0.87	0.76		-0.33	0.69	0.7	ELAB
GTBP	-0.13	-0.25	0.22	-0.19	-0.14	-0.29	-0.33		-0.16	-0.06	GTBP
REVB	0.09	0.84	0.57	0.84	0.76	0.86	0.69	-0.16		0.95	REVB
ARTL	0.14	0.87	0.59	0.87	0.83	0.84	0.7	-0.06	0.95		ARTL
	ATXI	WINT	CARM	PBM	LIPO	VRAX	ELAB	GTBP	REVB	ARTL

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

LIPO	+ 0.95	PBM
ARTL	+ 0.95	REVB
PBM	+ 0.87	WINT
ARTL	+ 0.87	WINT
ARTL	+ 0.87	PBM
ELAB	+ 0.87	LIPO

High negative correlations

GTBP	- 0.33	ELAB
GTBP	- 0.29	VRAX
GTBP	- 0.25	WINT
GTBP	- 0.19	PBM
REVB	- 0.16	GTBP
GTBP	- 0.14	LIPO

Risk-Adjusted Indicators

There is a big difference between Dermata Stock performing well and Dermata Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Dermata Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ATXI	4.52	0.34	0.02	(0.25)	6.34	(7.05)	14.47	(14.29)	39.28
WINT	7.96	(0.98)	0.00	(0.27)	0.00	0.00	20.00	(20.00)	58.33
CARM	10.70	(0.96)	0.00	0.47	0.00	0.00	22.92	(26.09)	73.18
PBM	5.55	(1.87)	0.00	(1.82)	0.00	0.00	8.10	(13.37)	63.42
LIPO	6.44	(1.40)	0.00	19.19	0.00	0.00	15.00	(15.15)	42.20
VRAX	5.01	(0.63)	0.00	(0.11)	0.00	0.00	8.20	(10.20)	92.80
ELAB	5.65	(1.68)	0.00	(0.62)	0.00	0.00	8.94	(14.03)	103.00
GTBP	6.37	0.25	0.03	0.20	8.79	(7.42)	12.73	(11.96)	74.56
REVB	2.93	(0.80)	0.00	(0.29)	0.00	0.00	5.50	(7.14)	19.41
ARTL	5.38	(1.20)	0.00	(65.52)	0.00	0.00	6.88	(11.08)	44.88

Dermata Therapeutics Corporate Management

Maria MBA	Senior Assurance	Profile
Gerald Proehl	President, Founder	Profile
Sean Proehl	Senior Development	Profile
David Hale	CoFounder Director	Profile
Dr MPH	Senior Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC